A teenager in Hull has become the first patient in the UK to be treated with Marstacimab, a new haemophilia B therapy that is easier to administer and offers hope for improved care, the Hull University Teaching Hospitals NHS Trust confirmed.
Hull Teen First in UK to Receive Innovative Haemophilia Treatment
< 1 min read
